To examine one health system’s response to the essential care of its hip fracture population during the COVID-19 pandemic and report on its effect on patient outcomes.
Prospective cohort study
Seven musculoskeletal care centers with New York City and Long Island.
Patients/Participants: 138 recent and 115 historical hip fracture patients.
Patients with hip fractures occurring between February 1, 2020 and April 15, 2020 or between February 1, 2019 and April 15, 2019 were prospectively enrolled in an orthopedic trauma registry and chart reviewed for demographic and hospital quality measures. Patients with recent hip fractures were identified as COVID positive (C+), COVID suspected (Cs) or COVID negative (C-).
Main Outcome Measurements:
Hospital quality measures, inpatient complications and mortality rates.
Seventeen (12.2%) patients were confirmed C+ by testing and another 14 (10.1%) were suspected (Cs) of having had the virus but were never tested. The C+ cohort, when compared to Cs and C- cohorts, had: an increased mortality rate (35.3% vs 7.1% vs 0.9%), increased length of hospital stay, a greater major complication rate and a greater incidence of ventilator need postoperatively.
COVID-19 had a devastating effect on the care of hip fracture patients during the pandemic. Although practice patterns generally remained unchanged, treating physicians need to understand the increased morbidity and mortality in hip fracture patients complicated by COVID-19.
Level of Evidence:
Prognostic Level III. See Instructions for Authors for a complete description of Levels of Evidence.